Moderna Financials
| M1RN34 Stock | BRL 12.05 0.04 0.33% |
Moderna |
Please note, the presentation of Moderna's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Moderna's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Moderna's management manipulating its earnings.
Moderna Stock Summary
Moderna competes with Novo Nordisk, Vertex Pharmaceuticals, BIONTECH, and BeiGene. Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1800 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | 200 Technology Square, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.modernatx.com |
| Phone | 617 714 6500 |
| Currency | BRL - Brazilian Real |
You should never invest in Moderna without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Moderna Stock, because this is throwing your money away. Analyzing the key information contained in Moderna's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Moderna Key Financial Ratios
Moderna's financial ratios allow both analysts and investors to convert raw data from Moderna's financial statements into concise, actionable information that can be used to evaluate the performance of Moderna over time and compare it to other companies across industries.Moderna Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Moderna's current stock value. Our valuation model uses many indicators to compare Moderna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Moderna competition to find correlations between indicators driving Moderna's intrinsic value. More Info.Moderna is regarded third in return on equity category among its peers. It is regarded fourth in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Moderna is roughly 2.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Moderna by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Moderna's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Moderna Systematic Risk
Moderna's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Moderna volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Moderna correlated with the market. If Beta is less than 0 Moderna generally moves in the opposite direction as compared to the market. If Moderna Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Moderna is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Moderna is generally in the same direction as the market. If Beta > 1 Moderna moves generally in the same direction as, but more than the movement of the benchmark.
Moderna December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Moderna help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Moderna. We use our internally-developed statistical techniques to arrive at the intrinsic value of Moderna based on widely used predictive technical indicators. In general, we focus on analyzing Moderna Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Moderna's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 15.77 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 5.45 |
Complementary Tools for Moderna Stock analysis
When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |